BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Guillot, Nicolas ^a   Kollins, Dmitrij ^a   Gilbert, Victoria ^a   Xavier, Sandhya ^b   Chen, Jun ^b   Gentle, Madeleine ^a   Reddy, Anand ^a   Bottinger, Erwin ^a   Jiang, Rulang ^c   Rastaldi, Maria Pia ^d   Corbelli, Alessandro ^d   Schlondorff, Detlef ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d Ospedale Maggior Policlinico and Fondazione D'Amico per la Ricerca sulle Malattie Renali   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN AND ACTIVIN RECEPTOR MEMBRANE BOUND INHIBITOR; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE SILENCING; GLOMERULUS CAPILLARY; GROWTH REGULATION; HEART MUSCLE; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY HYPERTROPHY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UNINEPHRECTOMY;

ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NEPHRECTOMY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84862668276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039406     Document Type: Article

References (55)

1. Massague J, (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178.
2. Goumans MJ, Liu Z, ten Dijke P, (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res 19: 116-127.
3. Massague J, Seoane J, Wotton D, (2005) Smad transcription factors. Genes Dev 19: 2783-2810.
4. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, et al. (1999) Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401: 480-485.
5. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324-1332.
6. Yan X, Lin Z, Chen F, Zhao X, Chen H, et al. (2009) Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem 284: 30097-30104.
7. Grotewold L, Plum M, Dildrop R, Peters T, Ruther U, (2001) Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech Dev 100: 327-330.
8. Higashihori N, Song Y, Richman JM, (2008) Expression and regulation of the decoy bone morphogenetic protein receptor BAMBI in the developing avian face. Dev Dyn 237: 1500-1508.
9. Sekiya T, Adachi S, Kohu K, Yamada T, Higuchi O, et al. (2004) Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem 279: 6840-6846.
10. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, et al. (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165-175.
11. Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, et al. (2008) Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol 14: 4880-4888.
12. Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R, (2007) The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 45: 482-486.
13. Goumans MJ, Mummery C, (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44: 253-265.
14. ten Dijke P, Arthur HM, (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8: 857-869.
15. Pardali E, ten Dijke P, (2009) Transforming growth factor-beta signaling and tumor angiogenesis. Front Biosci 14: 4848-4861.
16. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB, (1981) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A 78: 5339-5343.
17. Loveland KL, Bakker M, Meehan T, Christy E, von Schonfeldt V, et al. (2003) Expression of Bambi is widespread in juvenile and adult rat tissues and is regulated in male germ cells. Endocrinology 144: 4180-4186.
18. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753.
19. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817-828.
20. Seki T, Yun J, Oh SP, (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93: 682-689.
21. Orlova VV, Liu Z, Goumans MJ, Ten Dijke P, (2011) Controlling angiogenesis by two unique TGF-beta type I receptor signaling pathways. Histol Histopathol 26: 1219-1230.
22. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, et al. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97: 2626-2631.
23. Garcia-Cardena G, Gimbrone MA Jr, (2006) Biomechanical modulation of endothelial phenotype: implications for health and disease. Handb Exp Pharmacol pp. 79-95.
24. Chung AS, Ferrara N, (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27: 563-584.
25. Xavier S, Gilbert V, Rastaldi MP, Krick S, Kollins D, et al. (2010) BAMBI is expressed in endothelial cells and is regulated by lysosomal/autolysosomal degradation. PLoS One 5: e12995.
26. Chen J, Park HC, Addabbo F, Ni J, Pelger E, et al. (2008) Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 74: 879-889.
27. Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, et al. (2003) Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am J Pathol 162: 1431-1439.
28. Giardino L, Armelloni S, Corbelli A, Mattinzoli D, Zennaro C, et al. (2009) Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 20: 1929-1940.
29. Flyvbjerg A, Schrijvers BF, De Vriese AS, Tilton RG, Rasch R, (2002) Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. Am J Physiol Endocrinol Metab 283: E362-366.
30. Laitinen L, (1987) Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 19: 225-234.
31. Stan RV, Ghitescu L, Jacobson BS, Palade GE, (1999) Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 145: 1189-1198.
32. Muller WA, Ratti CM, McDonnell SL, Cohn ZA, (1989) A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170: 399-414.
33. Akishima Y, Ito K, Zhang L, Ishikawa Y, Orikasa H, et al. (2004) Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch 444: 153-157.
34. Vogt J, Traynor R, Sapkota GP, (2011) The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal 23: 1831-1842.
35. Fine L, (1986) The biology of renal hypertrophy. Kidney Int 29: 619-634.
36. Fine LG, Hammerman MR, Abboud HE, (1992) Evolving role of growth factors in the renal response to acute and chronic disease. J Am Soc Nephrol 2: 1163-1170.
37. Preisig P, (1999) What makes cells grow larger and how do they do it? Renal hypertrophy revisited. Exp Nephrol 7: 273-283.
38. Maynard SE, Karumanchi SA, (2011) Angiogenic factors and preeclampsia. Semin Nephrol 31: 33-46.
39. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
40. Lee NY, Blobe GC, (2007) The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem 282: 21507-21517.
41. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, et al. (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967.
42. Mulder KM, (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11: 23-35.
43. Ren B, Deng Y, Mukhopadhyay A, Lanahan AA, Zhuang ZW, et al. (2010) ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest 120: 1217-1228.
44. Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, et al. (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332: 361-365.
45. Eitenmuller I, Volger O, Kluge A, Troidl K, Barancik M, et al. (2006) The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res 99: 656-662.
46. Jalali S, Li YS, Sotoudeh M, Yuan S, Li S, et al. (1998) Shear stress activates p60src-Ras-MAPK signaling pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 18: 227-234.
47. Deindl E, (2007) Arteriogenesis: a focus on signal transduction cascades and transcription factors. Thromb Haemost 98: 940-943.
48. Iverson C, Larson G, Lai C, Yeh LT, Dadson C, et al. (2009) RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer. Cancer Res 69: 6839-6847.
49. Lamouille S, Mallet C, Feige JJ, Bailly S, (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100: 4495-4501.
50. Chang H, Zwijsen A, Vogel H, Huylebroeck D, Matzuk MM, (2000) Smad5 is essential for left-right asymmetry in mice. Dev Biol 219: 71-78.
51. Cunha SI, Pardali E, Thorikay M, Anderberg C, Hawinkels L, et al. (2010) Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med 207: 85-100.
52. Park SO, Lee YJ, Seki T, Hong KH, Fliess N, et al. (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111: 633-642.
53. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, et al. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 31: 918-924.
54. Sumpio BE, Yun S, Cordova AC, Haga M, Zhang J, et al. (2005) MAPKs (ERK1/2, p38) and AKT can be phosphorylated by shear stress independently of platelet endothelial cell adhesion molecule-1 (CD31) in vascular endothelial cells. J Biol Chem 280: 11185-11191.
55. Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, et al. (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332: 358-361.